- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x CYS: CYSTEINE(Non-covalent)
- 6 x COA: COENZYME A(Non-covalent)
COA.2: 24 residues within 4Å:- Chain A: H.166, L.185, Q.186, M.209, G.211, A.212, G.229, A.230, T.243, A.245, G.246, R.250, V.252
- Chain C: T.189, G.191, G.192, T.193, K.195, L.217, V.233, L.235, V.247, P.248
- Ligands: CYS.1
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:T.243
- Hydrogen bonds: A:A.212, A:A.230, A:A.230, A:T.243, A:R.250, C:T.193
- Salt bridges: A:K.227, C:K.195, C:K.195
COA.4: 21 residues within 4Å:- Chain B: H.166, L.185, G.211, A.212, K.227, G.229, A.230, T.243, A.245, G.246, V.252
- Chain F: T.189, G.191, G.192, T.193, L.217, V.233, L.235, V.247, P.248
- Ligands: CYS.3
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain F- Hydrophobic interactions: B:K.227
- Hydrogen bonds: B:A.212, B:A.230, B:A.230, B:T.243, B:G.246, F:G.192, F:T.193
COA.6: 24 residues within 4Å:- Chain C: H.166, L.185, Q.186, M.209, G.211, A.212, G.229, A.230, T.243, A.245, G.246, R.250, V.252
- Chain E: T.189, G.191, G.192, T.193, K.195, L.217, V.233, L.235, V.247, P.248
- Ligands: CYS.5
10 PLIP interactions:7 interactions with chain C, 3 interactions with chain E- Hydrophobic interactions: C:T.243
- Hydrogen bonds: C:A.212, C:A.230, C:A.230, C:T.243, C:R.250, E:T.193
- Salt bridges: C:K.227, E:K.195, E:K.195
COA.8: 21 residues within 4Å:- Chain B: T.189, G.191, G.192, T.193, L.217, V.233, L.235, V.247, P.248
- Chain D: H.166, L.185, G.211, A.212, K.227, G.229, A.230, T.243, A.245, G.246, V.252
- Ligands: CYS.7
7 PLIP interactions:2 interactions with chain B, 5 interactions with chain D- Hydrogen bonds: B:G.192, B:T.193, D:A.212, D:A.230, D:A.230, D:G.246
- Hydrophobic interactions: D:K.227
COA.10: 24 residues within 4Å:- Chain A: T.189, G.191, G.192, T.193, K.195, L.217, V.233, L.235, V.247, P.248
- Chain E: H.166, L.185, Q.186, M.209, G.211, A.212, G.229, A.230, T.243, A.245, G.246, R.250, V.252
- Ligands: CYS.9
9 PLIP interactions:6 interactions with chain E, 3 interactions with chain A- Hydrophobic interactions: E:T.243
- Hydrogen bonds: E:A.212, E:A.230, E:A.230, E:R.250, A:T.193
- Salt bridges: E:K.227, A:K.195, A:K.195
COA.12: 21 residues within 4Å:- Chain D: T.189, G.191, G.192, T.193, L.217, V.233, L.235, V.247, P.248
- Chain F: H.166, L.185, G.211, A.212, K.227, G.229, A.230, T.243, A.245, G.246, V.252
- Ligands: CYS.11
8 PLIP interactions:6 interactions with chain F, 2 interactions with chain D- Hydrophobic interactions: F:K.227
- Hydrogen bonds: F:A.212, F:A.230, F:A.230, F:T.243, F:G.246, D:G.192, D:T.193
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Toyomoto, T. et al., Alkyl gallates inhibit serine O -acetyltransferase in bacteria and enhance susceptibility of drug-resistant Gram-negative bacteria to antibiotics. Front Microbiol (2023)
- Release Date
- 2023-11-22
- Peptides
- Serine acetyltransferase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x CYS: CYSTEINE(Non-covalent)
- 6 x COA: COENZYME A(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Toyomoto, T. et al., Alkyl gallates inhibit serine O -acetyltransferase in bacteria and enhance susceptibility of drug-resistant Gram-negative bacteria to antibiotics. Front Microbiol (2023)
- Release Date
- 2023-11-22
- Peptides
- Serine acetyltransferase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B